Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junhao Zheng

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Cancer Gene Therapy|October 12, 2023
Exploration of a screening model for intrahepatic cholangiocarcinoma patients prone to cuproptosis and mechanisms of the susceptibility of CD274-knockdown intrahepatic cholangiocarcinoma cells to cuproptosisZefeng Shen, Jingwei Cai, Liye Tao, et al.
BMC Surgery|March 21, 2021
Differentiation and management of hepatobiliary mucinous cystic neoplasms: a single centre experience for 8 yearsJiaqi Gao, Junhao Zheng, Jingwei Cai, et al.
World Journal of Urology|February 20, 2025
Is it necessary for patients with a positive urine culture to achieve a negative result after antimicrobial treatment before undergoing percutaneous nephrolithotomy?Junhao Zheng, Qixian Guo, Gaoyuanzhi Yue, et al.
Signal Transduction and Targeted Therapy|May 18, 2021
UBQLN1 mediates sorafenib resistance through regulating mitochondrial biogenesis and ROS homeostasis by targeting PGC1β in hepatocellular carcinomaJunjie Xu, Lin Ji, Yeling Ruan, et al.
World Journal of Surgical Oncology|April 9, 2023
Safety and feasibility of laparoscopic liver resection for intrahepatic cholangiocarcinoma: a propensity score-matched studyZefeng Shen, Liye Tao, Jingwei Cai, et al.
Hepatology International|June 22, 2023
Activation of IGFBP4 via unconventional mechanism of miRNA attenuates metastasis of intrahepatic cholangiocarcinomaLiye Tao, Yali Wang, Zefeng Shen, et al.
Molecular Cancer|November 23, 2020
N<sup>6</sup>-methyladenosine-modified CircRNA-SORE sustains sorafenib resistance in hepatocellular carcinoma by regulating β-catenin signalingJunjie Xu, Zhe Wan, Minyue Tang, et al.
Cancer Medicine|December 27, 2025
A Novel MPT-Driven Necrosis-Related lncRNA Signature for Prognostic Prediction in Hepatocellular Carcinoma: Validation Using OrganoidsYang Liu, Liye Tao, Zefeng Shen, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 13, 2023
Circ-RAPGEF5 promotes intrahepatic cholangiocarcinoma progression by stabilizing SAE1 to facilitate SUMOylationJunhao Zheng, Yali Wang, Liye Tao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 20, 2024
Synergistic Anticancer Strategy Targeting ECM Stiffness: Integration of Matrix Softening and Mechanical Signal Transduction Blockade in Primary Liver CancersZefeng Shen, Liye Tao, Yali Wang, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Cancer Gene Therapy|October 12, 2023
Exploration of a screening model for intrahepatic cholangiocarcinoma patients prone to cuproptosis and mechanisms of the susceptibility of CD274-knockdown intrahepatic cholangiocarcinoma cells to cuproptosisZefeng Shen, Jingwei Cai, Liye Tao, et al.
BMC Surgery|March 21, 2021
Differentiation and management of hepatobiliary mucinous cystic neoplasms: a single centre experience for 8 yearsJiaqi Gao, Junhao Zheng, Jingwei Cai, et al.
World Journal of Urology|February 20, 2025
Is it necessary for patients with a positive urine culture to achieve a negative result after antimicrobial treatment before undergoing percutaneous nephrolithotomy?Junhao Zheng, Qixian Guo, Gaoyuanzhi Yue, et al.
Signal Transduction and Targeted Therapy|May 18, 2021
UBQLN1 mediates sorafenib resistance through regulating mitochondrial biogenesis and ROS homeostasis by targeting PGC1β in hepatocellular carcinomaJunjie Xu, Lin Ji, Yeling Ruan, et al.
World Journal of Surgical Oncology|April 9, 2023
Safety and feasibility of laparoscopic liver resection for intrahepatic cholangiocarcinoma: a propensity score-matched studyZefeng Shen, Liye Tao, Jingwei Cai, et al.
Hepatology International|June 22, 2023
Activation of IGFBP4 via unconventional mechanism of miRNA attenuates metastasis of intrahepatic cholangiocarcinomaLiye Tao, Yali Wang, Zefeng Shen, et al.
Molecular Cancer|November 23, 2020
N<sup>6</sup>-methyladenosine-modified CircRNA-SORE sustains sorafenib resistance in hepatocellular carcinoma by regulating β-catenin signalingJunjie Xu, Zhe Wan, Minyue Tang, et al.
Cancer Medicine|December 27, 2025
A Novel MPT-Driven Necrosis-Related lncRNA Signature for Prognostic Prediction in Hepatocellular Carcinoma: Validation Using OrganoidsYang Liu, Liye Tao, Zefeng Shen, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 13, 2023
Circ-RAPGEF5 promotes intrahepatic cholangiocarcinoma progression by stabilizing SAE1 to facilitate SUMOylationJunhao Zheng, Yali Wang, Liye Tao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 20, 2024
Synergistic Anticancer Strategy Targeting ECM Stiffness: Integration of Matrix Softening and Mechanical Signal Transduction Blockade in Primary Liver CancersZefeng Shen, Liye Tao, Yali Wang, et al.
Pageof 6